{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-008169","form_type":"8-K","ticker":"IMDX","cik":"0001642380","company_name":"Insight Molecular Diagnostics Inc.","filed_at":"2026-02-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.728172+00:00","generated_at":"2026-05-15T23:38:22.765261+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Insight Molecular Diagnostics enters specimen collection pact with Quest for GraftAssureCore test","bullets":["Agreement with Quest Diagnostics dated Feb 20, 2026 for specimen collection services related to GraftAssureCore dd-cfDNA test.","Quest will provide services for the PCR-based blood test measuring donor-derived cell free DNA.","Parties also agree to negotiate additional rights to GraftAssure technology for a specified period.","Specific fees and financial terms not disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-008169","json":"https://secwatch.observer/filing/0001493152-26-008169.json","markdown":"https://secwatch.observer/filing/0001493152-26-008169.md","text":"https://secwatch.observer/filing/0001493152-26-008169.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642380/000149315226008169/0001493152-26-008169-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642380/000149315226008169/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T23:38:22.765261+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b46d04e430cb560d3e0e898af7f88b46d369f815","claim":"Insight Molecular Diagnostics Inc. entered into Specimen Collection Agreement with Quest Diagnostics Incorporated (effective 2026-02-20).","evidence_excerpt":"On February 20, 2026, Insight Molecular Diagnostics Inc. (the “Company”) entered into a Specimen Collection Agreement (the “Agreement”) with Quest Diagnostics Incorporated (“Quest Diagnostics”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1642380/000149315226008169/0001493152-26-008169-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"supply"},{"label":"Counterparty","value":"Quest Diagnostics Incorporated"},{"label":"Effective","value":"2026-02-20"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}